Aug 25, 2020

Chugai Selected as Digital Transformation Stock (DX Stock) 2020

  • DX Stock 2020 is jointly selected by METI and TSE to accelerate the digital transformation of Japanese companies
  • 35 companies were selected from a pool of approximately 3,800 listed companies in Japan
  • Chugai is the only company selected as DX Stock 2020 in the pharmaceutical industry

TOKYO, August 25, 2020 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that it has been selected as one of the “Digital Transformation Stocks (DX Stocks) 2020” by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE). “DX Stocks” are designated to companies that have fundamentally transformed their business models and other aspects of their business based on the premise that digital technology will lead to new growth and enhanced competitiveness.

In recent years, with the spread of digital technologies such as AI, IoT, and Big Data, the trend of Dx has become apparent worldwide by moving beyond the realm of “utilizing IT for business” and use digital technology as a precondition for fundamentally transforming business models, organizations, operations, corporate culture, and culture to realize customer value in order to achieve new growth and strengthen competitiveness. METI and TSE have jointly selected and announced the DX Stocks with an aim to accelerate the digital transformation of Japanese companies in preparation for the arrival of the fully-fledged digital age. 35 companies were selected from a pool of approximately 3,800 listed companies in Japan based on the following criteria: 1) business transformation, 2) strategic initiatives, and 3) management leadership.

DX Stocks 2020 logo

With our CHUGAI DIGITAL VISION 2030, we aim to become a top innovator in providing healthcare solutions that use digital technology to innovate our business and change society. Chugai is committed to transforming its business and providing healthcare solutions that will change society through three basic strategies: 1) strengthening digital platforms, 2) optimize all value chains, and 3) digital transformation for drug discovery and development.

[References]
CHUGAI DIGITAL website
https://www.chugai-pharm.co.jp/english/profile/digital/index.html

CHUGAI DIGITAL concept movie (Japanese only)
https://youtu.be/SWOYtFX5-1U

CHUGAI DIGITAL logo

Contact:

  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Tomoko Shimizu
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Toshiya Sasai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp
  • Like
  • Tweet
  • LINE it!
  • E-mail
Back to top